Research Article

Hypercoordinated Organosilicon(IV) and Organotin(IV) Complexes: Syntheses, Spectral Studies, and Antimicrobial Activity In Vitro

Table 3

13C NMR chemical shifts of the ligands and their metal complexes.

CompoundC1/C2C3/C4C5/C6C7/C8C9/C10C11/C12M–CH3

HL1123.18/127.64130.46/130.87135.12/134.75162.36/153.96158.47/10.2918.90
Me2SiCl(L1)122.06/128.04130.68/130.96136.93/135.42166.84/147.99154.43/20.1912.7831.43
Me2Si(L1)2121.93/127.05130.72/130.81136.26/133.92167.25/147.09153.23/21.8112.0529.34
Me2SnCl(L1)122.27/127.32129.92/131.03136.43/133.98165.23/149.06153.92/19.5312.8933.89
Me2Sn(L1)2122.67/127.08130.77/130.97136.39/134.41164.89/149.48153.54/18.9714.4431.54
HL2123.18/127.58130.47/130.93135.13/134.75162.38/152.88158.50/13.6219.47/26.97
Me2SiCl(L2)122.94/127.43129.78/131.25136.78/134.17163.79/151.56154.26/22.1215.65/22.1430.45
Me2Si(L2)2122.71/127.49131.75/131.13136.91/135.54164.21/150.97155.03/19.9624.97/18.5833.86
Me2SnCl(L2)123.69/127.39130.98/131.06136.79/134.23164.02/151.39154.89/23.5319.06/19.3632.42
Me2Sn(L1)2121.91/127.26130.74/130.74137.13/134.72163.89/152.03154.38/21.2623.02/14.7734.53

356802.fig.005